Pandemic precautions have raised the standard for efficient, remote-enabled healthcare solutions. Using leading-edge technology, many data-collecting heath devices are now categorized as IoT and allow for greater awareness of vitals and other metrics for both the user and medical professionals. Smart wearables are taking the tremendous popularity of personal devices and bringing advanced diagnostic elements to the fore.
AI solutions for out-patient needs are becoming increasingly crucial, as medical facilities are overwhelmed with COVID-19 cases and practitioners are desperate for any possible reduction in workflow breadth. Nonetheless, the current surge of smart wearables is actually due in large part to interest from tech-savvy consumers. The acceptance of smartwatches into daily routines and rudimentary health assessments has normalized the concept of AI-driven, internet-connected wearables. It’s unsurprising that this market is poised to ship up to 776 million units by 2026, and withstood pandemic limitations to deliver 266 million units last year.
Rockley Photonics is ready to capitalize on this with its all-encompassing “clinic-on-the-wrist.” The digital health sensor system tracks a number of biomarkers, such as blood pressure, hydration, and core body temperature. More specific and situational measurements include glucose and lactate levels, as well as blood alcohol content. Rockley’s device uses infrared spectrophotometers instead of diodes in order to cover a larger spectrum of biomarkers. This innovation is set to become the pinnacle of smart wearables by being able to supply a consistent, hands-off supervision of vitals at a professional-quality standard.
